![Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5938/TOC-Subject-Sample-2021-Health-Social-Care.jpg"})
Abstract
Because of the increasing duration of the waiting-list period for kidney transplantation, we hypothesized that this period was associated with a progressive increase in depressive and anxious symptoms in patients waitlisted for a kidney transplantation. In a prospective naturalistic follow-up cohort study, 390 patients on a waiting list for kidney transplant were assessed for anxiety and depression at the time of inclusion on the waiting list, 12 months later, 24 months later, and 3 months after transplantation. The Beck Depression Inventory–Short Version (Short-BDI) and the State and Trait Anxiety Inventory (STAI) were used for this assessment. We found that in this sample, anxious and depressive symptoms progressively increased before transplantation and showed a marked decrease after transplantation. We conclude that to limit anxious and depressive symptoms in patients waiting for a kidney transplantation, the duration of the waiting list period should be reduced as far as possible.
ACKNOWLEDGMENTS
Research support for this study was obtained through grants from the French Ministry of Health and Assistance Publique-Hôpitaux de Paris. The authors also thank the French National Federation for Patients with End-Stage Renal Diseases (FNAIR; Fédération Nationale d’Aide aux Insuffisants Rénaux) for their assistance in this study, the patients for their time, effort, and willingness to participate, the French Ministry of Health, as well as and Assistance Publique-Hôpitaux de Paris.
